NDC 63323-417
Cisatracurium
Cisatracurium Besylate
Cisatracurium is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Cisatracurium Besylate.
Product ID | 63323-417_0d662c1d-2eef-4e5f-8610-fe606716c810 |
NDC | 63323-417 |
Product Type | Human Prescription Drug |
Proprietary Name | Cisatracurium |
Generic Name | Cisatracurium Besylate |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2015-02-26 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA203183 |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | CISATRACURIUM BESYLATE |
Active Ingredient Strength | 2 mg/mL |
Pharm Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |